tiprankstipranks
Trending News
More News >
Lantern Pharma, Inc. (LTRN)
NASDAQ:LTRN
US Market

Lantern Pharma (LTRN) Income Statement

Compare
312 Followers

Lantern Pharma Income Statement

Last quarter (Q3 2025), Lantern Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Lantern Pharma's net income was $-4.18M. See Lantern Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -174.84K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 22.22M$ 17.70M$ 14.43M$ 12.59M$ 5.91M
Depreciation and Amortization
$ 17.28K$ 174.84K$ 10.08K$ 6.76K$ 3.39K
EBITDA
$ -22.20M$ -15.79M$ -14.42M$ -12.58M$ -5.90M
Operating Income
$ -22.22M$ -17.88M$ -14.43M$ -12.59M$ -5.91M
Other Income/Expenses
$ 1.44M$ 1.92M$ 172.81K$ 228.48K$ 0.00
Pretax Income
$ -20.78M$ -15.96M$ -14.26M$ -12.36M$ -5.91M
Net Income
$ -20.78M$ -15.96M$ -14.26M$ -12.36M$ -5.91M
Per Share Metrics
Basic EPS
$ -1.93K$ -1.47$ -1.31$ -1.13$ -0.95
Diluted EPS
$ -1.93K$ -1.47$ -1.31$ -1.13$ -0.95
Weighted Average Shares Outstanding
10.76M 10.84M 10.85M 10.90M 6.22M
Weighted Average Shares Outstanding (Diluted)
10.76M 10.84M 10.85M 10.90M 6.22M
Currency in USD

Lantern Pharma Earnings and Revenue History